Phuong N. Huynh

Array ( [id] => 7719814 [patent_doc_number] => 20120009149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'Tetrameric Cytokines with Improved Biological Activity' [patent_app_type] => utility [patent_app_number] => 13/219940 [patent_app_country] => US [patent_app_date] => 2011-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 24282 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20120009149.pdf [firstpage_image] =>[orig_patent_app_number] => 13219940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9552438 [patent_doc_number] => 08759489 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and method for preparing the same' [patent_app_type] => utility [patent_app_number] => 13/217050 [patent_app_country] => US [patent_app_date] => 2011-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 15 [patent_no_of_words] => 10977 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13217050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817973 [patent_doc_number] => 20120064593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'SUPERANTIBODY SYNTHESIS AND USE IN DETECTION, PREVENTION AND TREATMENT OF DISEASE' [patent_app_type] => utility [patent_app_number] => 13/215952 [patent_app_country] => US [patent_app_date] => 2011-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 16833 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064593.pdf [firstpage_image] =>[orig_patent_app_number] => 13215952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9676335 [patent_doc_number] => 08815243 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => 'Pharmaceutical composition with antibody that binds to heat shock protein 27(HSP270) and method for promoting wound healing' [patent_app_type] => utility [patent_app_number] => 13/817760 [patent_app_country] => US [patent_app_date] => 2011-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6156 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650893 [patent_doc_number] => 20110300162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'DRUG CONJUGATE COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/212694 [patent_app_country] => US [patent_app_date] => 2011-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11231 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300162.pdf [firstpage_image] =>[orig_patent_app_number] => 13212694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650797 [patent_doc_number] => 20110300066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'Combination Therapy With Anti-CD74 Antibodies Provides Enhanced Toxicity to Malignancies, Autoimmune Disease and Other Diseases' [patent_app_type] => utility [patent_app_number] => 13/209954 [patent_app_country] => US [patent_app_date] => 2011-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 43317 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300066.pdf [firstpage_image] =>[orig_patent_app_number] => 13209954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817487 [patent_doc_number] => 20120064107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND OTHER DISEASE' [patent_app_type] => utility [patent_app_number] => 13/208755 [patent_app_country] => US [patent_app_date] => 2011-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 92 [patent_figures_cnt] => 92 [patent_no_of_words] => 124889 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13208755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9964995 [patent_doc_number] => 09012609 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-21 [patent_title] => 'Anti-serum albumin binding variants' [patent_app_type] => utility [patent_app_number] => 13/816515 [patent_app_country] => US [patent_app_date] => 2011-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 36 [patent_no_of_words] => 21617 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561289 [patent_doc_number] => 20110275122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'THROMBOPOIETIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/186443 [patent_app_country] => US [patent_app_date] => 2011-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39525 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275122.pdf [firstpage_image] =>[orig_patent_app_number] => 13186443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7731530 [patent_doc_number] => 20120014949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'Serum Biomarkers For Early Detection Of Acute Cellular Rejection' [patent_app_type] => utility [patent_app_number] => 13/185306 [patent_app_country] => US [patent_app_date] => 2011-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14411 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20120014949.pdf [firstpage_image] =>[orig_patent_app_number] => 13185306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8663977 [patent_doc_number] => 08377437 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => 'C3b antibodies and methods for the prevention and treatment of complement-associated disorders' [patent_app_type] => utility [patent_app_number] => 13/135907 [patent_app_country] => US [patent_app_date] => 2011-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 27300 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13135907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9085820 [patent_doc_number] => 08557243 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-15 [patent_title] => 'EFGR antibodies comprising modular recognition domains' [patent_app_type] => utility [patent_app_number] => 13/135789 [patent_app_country] => US [patent_app_date] => 2011-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 29 [patent_no_of_words] => 30431 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13135789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9126631 [patent_doc_number] => 08574577 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-05 [patent_title] => 'VEGF antibodies comprising modular recognition domains' [patent_app_type] => utility [patent_app_number] => 13/135788 [patent_app_country] => US [patent_app_date] => 2011-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 29 [patent_no_of_words] => 30420 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13135788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9085819 [patent_doc_number] => 08557242 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-15 [patent_title] => 'ERBB2 antibodies comprising modular recognition domains' [patent_app_type] => utility [patent_app_number] => 13/135786 [patent_app_country] => US [patent_app_date] => 2011-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 29 [patent_no_of_words] => 30423 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13135786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8845783 [patent_doc_number] => 08454960 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Multispecific antibody targeting and multivalency through modular recognition domains' [patent_app_type] => utility [patent_app_number] => 13/135754 [patent_app_country] => US [patent_app_date] => 2011-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 29 [patent_no_of_words] => 30424 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13135754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7731712 [patent_doc_number] => 20120015024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'METHODS FOR TREATING TWEAK-RELATED CONDITIONS' [patent_app_type] => utility [patent_app_number] => 13/179096 [patent_app_country] => US [patent_app_date] => 2011-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 18947 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13179096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650836 [patent_doc_number] => 20110300105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo' [patent_app_type] => utility [patent_app_number] => 13/178092 [patent_app_country] => US [patent_app_date] => 2011-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 20944 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300105.pdf [firstpage_image] =>[orig_patent_app_number] => 13178092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8041377 [patent_doc_number] => 20120070428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'TREATMENT OF VASCULARIZED PIGMENT EPITHELIAL DETACHMENT WITH ANTI-VEGF THERAPY' [patent_app_type] => utility [patent_app_number] => 13/175454 [patent_app_country] => US [patent_app_date] => 2011-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2969 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20120070428.pdf [firstpage_image] =>[orig_patent_app_number] => 13175454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7579764 [patent_doc_number] => 20110293647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'IMMUNOGENIC LHRH COMPOSITIONS AND METHODS RELATING THERETO' [patent_app_type] => utility [patent_app_number] => 13/167438 [patent_app_country] => US [patent_app_date] => 2011-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7168 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20110293647.pdf [firstpage_image] =>[orig_patent_app_number] => 13167438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8963013 [patent_doc_number] => 20130202615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-08 [patent_title] => 'ANTI-VEGF ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/703947 [patent_app_country] => US [patent_app_date] => 2011-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 31091 [patent_no_of_claims] => 105 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13703947 [rel_patent_id] =>[rel_patent_doc_number] =>)